Journal of Clinical Developmental Biology

Abstract

Increasing report of persistent and  disabling symptoms after recovery from acute COVID -19 have been reported and that have termed as “ Long COVID “ and  it occur in 10% to 30% of cases .On neurological point of view patients describe memory impairment abs concentration , described as “ brain fog “ and is highly suggestive of chronic fatigue syndrome. Although a specific treatment is not yet validated to treat Long COVID syndrome , we reported our experience with ivermectin in such patients.We treated 50 patients with 0,2 mg /kg  to 0,4 mg/kg for 3 to 7 days according symptomatic expression ( mild to moderate ). We found a  resolution in 85% of the patients treated with Ivermectin.

Our experience suggest that ivermectin could be a gold standard  treatment in long  COVID neurological symptoms .Further studies are needed to confirm this data.